OBJECTIVE: Single-dose nevirapine (NVP) (sdNVP) can reduce the risk of HIV vertical transmission. We assessed risk factors for NVP resistance in plasma and breast milk from sdNVP-exposed Ugandan women. METHODS: Samples were analyzed using the Roche AMPLICOR HIV-1 Monitor Test Kit, version 1.5, and the ViroSeq HIV-1 Genotyping System. NVP concentrations were determined by liquid chromatography with tandem mass spectroscopy. RESULTS: HIV genotypes (plasma and breast milk) were obtained for 30 women 4 weeks after sdNVP (HIV subtypes: 15A, 1C, 12D, two recombinant). NVP resistance was detected in 12 (40%) of 30 breast milk samples. There was a nonsignificant trend between detection of NVP resistance in breast milk and plasma (P = 0.06). There was no association of HIV resistance in breast milk with median maternal pre-NVP viral load or CD4 cell count, median breast milk viral load at 4 weeks, breast milk sodium more than 10 mmol/l, HIV subtype, or concentration of NVP in breast milk or plasma. CONCLUSION: NVP resistance was frequently detected in breast milk 4 weeks after sdNVP exposure. In this study, we were unable to identify specific factors associated with breast milk NVP resistance.
OBJECTIVE: Single-dose nevirapine (NVP) (sdNVP) can reduce the risk of HIV vertical transmission. We assessed risk factors for NVP resistance in plasma and breast milk from sdNVP-exposed Ugandan women. METHODS: Samples were analyzed using the Roche AMPLICOR HIV-1 Monitor Test Kit, version 1.5, and the ViroSeq HIV-1 Genotyping System. NVP concentrations were determined by liquid chromatography with tandem mass spectroscopy. RESULTS: HIV genotypes (plasma and breast milk) were obtained for 30 women 4 weeks after sdNVP (HIV subtypes: 15A, 1C, 12D, two recombinant). NVP resistance was detected in 12 (40%) of 30 breast milk samples. There was a nonsignificant trend between detection of NVP resistance in breast milk and plasma (P = 0.06). There was no association of HIV resistance in breast milk with median maternal pre-NVP viral load or CD4 cell count, median breast milk viral load at 4 weeks, breast milk sodium more than 10 mmol/l, HIV subtype, or concentration of NVP in breast milk or plasma. CONCLUSION: NVP resistance was frequently detected in breast milk 4 weeks after sdNVP exposure. In this study, we were unable to identify specific factors associated with breast milk NVP resistance.
Authors: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Elizabeth R Brown; Shawn P Cunningham; Philippa Musoke; Francis Mmiro; J Brooks Jackson Journal: J Acquir Immune Defic Syndr Date: 2004-02-01 Impact factor: 3.731
Authors: Eva Muro; Jacqueline A H Droste; Hadewych Ter Hofstede; Marjolein Bosch; Wil Dolmans; David M Burger Journal: J Acquir Immune Defic Syndr Date: 2005-08-01 Impact factor: 3.731
Authors: R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa Journal: J Clin Microbiol Date: 1990-03 Impact factor: 5.948
Authors: Esther J Lee; Rami Kantor; Lynn Zijenah; Wayne Sheldon; Lynda Emel; Patrick Mateta; Elizabeth Johnston; Jennifer Wells; Avinash K Shetty; Hoosen Coovadia; Yvonne Maldonado; Samuel Adeniyi Jones; Lynne M Mofenson; Christopher H Contag; Mary Bassett; David A Katzenstein Journal: J Infect Dis Date: 2005-08-23 Impact factor: 5.226
Authors: P Musoke; L A Guay; D Bagenda; M Mirochnick; C Nakabiito; T Fleming; T Elliott; S Horton; K Dransfield; J W Pav; A Murarka; M Allen; M G Fowler; L Mofenson; D Hom; F Mmiro; J B Jackson Journal: AIDS Date: 1999-03-11 Impact factor: 4.177
Authors: Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha Taha Journal: J Infect Dis Date: 2005-06-01 Impact factor: 5.226
Authors: S H Eshleman; M Mracna; L A Guay; M Deseyve; S Cunningham; M Mirochnick; P Musoke; T Fleming; M Glenn Fowler; L M Mofenson; F Mmiro; J B Jackson Journal: AIDS Date: 2001-10-19 Impact factor: 4.177
Authors: Seble Kassaye; Esther Lee; Rami Kantor; Elizabeth Johnston; Mark Winters; Lynn Zijenah; Patrick Mateta; David Katzenstein Journal: AIDS Res Hum Retroviruses Date: 2007-08 Impact factor: 2.205
Authors: Soren Gantt; Rachel Payant; Jacquelyn Carlsson; Mark A Micek; Ana Judith Blanco; Ingrid A Beck; Laurinda Matunha; Pablo Montoya; Eduardo Matediana; Stephen Gloyd; Lisa M Frenkel Journal: J Pediatric Infect Dis Soc Date: 2012-07-03 Impact factor: 3.164